Author: Hibino, Makoto; Kondo, Tetsuri
Title: Interstitial Pneumonia Associated with the Influenza Vaccine: A Report of Two Cases Document date: 2017_1_15
ID: jnfg3gyt_11
Snippet: Influenza is a seasonal, contagious respiratory illness that is mostly mild and self-limited, although occasional severe manifestations may lead to hospitalization and even death. In 2009, there was a worldwide influenza A(H1N1)pdm09 pandemic with an increased propensity to infect the lower respiratory tract and the ability to cause the most serious form of acute respiratory distress syndrome secondary to pneumonia (3). Currently, the virus is se.....
Document: Influenza is a seasonal, contagious respiratory illness that is mostly mild and self-limited, although occasional severe manifestations may lead to hospitalization and even death. In 2009, there was a worldwide influenza A(H1N1)pdm09 pandemic with an increased propensity to infect the lower respiratory tract and the ability to cause the most serious form of acute respiratory distress syndrome secondary to pneumonia (3). Currently, the virus is seasonal in humans. Traditionally, the influenza vaccine is received by numerous individuals worldwide, particularly those at a high risk of developing influenza-related complications, because it decreases the incidence of the disease and the risk of more serious outcomes (1, 2). The vaccine against the A(H1N1)pdm09 virus was developed in 2009, and its effectiveness and safety are considered to be similar to those of previous vaccines (4). In 2009, monovalent A(H1N1)pdm09 vaccines became available, followed by seasonal influenza vaccines containing the A(H1N1)pdm09-like antigen in 2010.
Search related documents:
Co phrase search for related documents- acute respiratory pneumonia secondary distress syndrome and high risk: 1
- acute respiratory pneumonia secondary distress syndrome and pneumonia secondary distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acute respiratory pneumonia secondary distress syndrome and respiratory illness: 1
- acute respiratory pneumonia secondary distress syndrome and respiratory pneumonia secondary distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- acute respiratory pneumonia secondary distress syndrome and respiratory tract: 1
- acute respiratory pneumonia secondary distress syndrome and safety effectiveness: 1
- death hospitalization and disease incidence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- death hospitalization and distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- death hospitalization and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- death hospitalization and influenza vaccine: 1, 2, 3, 4, 5
- death hospitalization and previous vaccine: 1
- death hospitalization and respiratory illness: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- death hospitalization and respiratory tract: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- death hospitalization and safety effectiveness: 1, 2, 3, 4, 5, 6, 7, 8
- death hospitalization and severe manifestation: 1
- death hospitalization and virus vaccine: 1, 2, 3
- death hospitalization and worldwide influenza: 1
- disease incidence and distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
- disease incidence and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
Co phrase search for related documents, hyperlinks ordered by date